Trials / Sponsors / Recursion Pharmaceuticals Inc.
Recursion Pharmaceuticals Inc.
Industry · 6 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | A Study of REC-1245 in Participants With Unresectable, Locally Advanced, or Metastatic Cancer Unresectable, Locally Advanced, Metastatic Cancers | Phase 1 / Phase 2 | 2024-11-21 |
| Terminated | The Clostridioides Difficile Trial of REC-3964 Recurrent Clostridioides Difficile Infection | Phase 2 | 2024-10-14 |
| Terminated | A Study of REC-4881 in Participants With Cancers Which Have an AXIN1 or APC Mutation AXIN1 Gene Mutation, APC Gene Mutation, Solid Tumor | Phase 2 | 2024-01-15 |
| Recruiting | Evaluate REC-4881 in Participants With Familial Adenomatous Polyposis (FAP) Familial Adenomatous Polyposis | Phase 1 / Phase 2 | 2023-07-10 |
| Terminated | Efficacy and Safety of REC-2282 in Patients With Progressive Neurofibromatosis Type 2 (NF2) Mutated Meningioma Neurofibromatosis Type 2 | Phase 2 / Phase 3 | 2022-06-20 |
| Completed | The Symptomatic Cerebral Cavernous Malformation Trial of REC-994 Cerebral Cavernous Malformation | Phase 2 | 2022-03-17 |